Andreas Jeromin

18.0k total citations · 4 hit papers
183 papers, 9.0k citations indexed

About

Andreas Jeromin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Andreas Jeromin has authored 183 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 66 papers in Cellular and Molecular Neuroscience and 41 papers in Neurology. Recurrent topics in Andreas Jeromin's work include Neuroscience and Neuropharmacology Research (45 papers), Cellular transport and secretion (32 papers) and Alzheimer's disease research and treatments (31 papers). Andreas Jeromin is often cited by papers focused on Neuroscience and Neuropharmacology Research (45 papers), Cellular transport and secretion (32 papers) and Alzheimer's disease research and treatments (31 papers). Andreas Jeromin collaborates with scholars based in United States, Canada and United Kingdom. Andreas Jeromin's co-authors include John Roder, Stefania Mondello, Kaj Blennow, David Hanlon, Henrik Zetterberg, Linan Song, J Chevesich, Paul D. Wes, Gail Stetten and Craig Montell and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Andreas Jeromin

176 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TRPC1, a human homolog of a Drosophila store-operated channel.

1995 522 citations Andreas Jeromin et al. Proceedings of the National Academy of Sciences profile →
Plasma β-amyloid in Alzheimer’s disease and vascular disease

2016 447 citations Shorena Janelidze, Henrik Zetterberg et al. Scientific Reports profile →
Plasma tau in Alzheimer disease

2016 378 citations Henrik Zetterberg, Shorena Janelidze et al. profile →
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

2021 146 citations Andreas Jeromin, Nicholas J. Ashton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Jeromin United States	54	4.2k	2.7k	2.0k	2.0k	1.1k	183	9.0k
Gabriele Siciliano Italy	52	4.6k 1.1×	2.3k 0.9×	2.2k 1.1×	2.6k 1.3×	493 0.4×	429	10.1k
Michael Tymianski Canada	58	5.8k 1.4×	5.9k 2.2×	1.7k 0.8×	3.2k 1.6×	701 0.6×	195	14.5k
Christian Waeber United States	61	5.1k 1.2×	4.6k 1.7×	1.6k 0.8×	893 0.5×	535 0.5×	137	10.8k
Stephen D. Skaper Italy	67	5.5k 1.3×	6.2k 2.3×	2.5k 1.2×	1.4k 0.7×	976 0.9×	277	15.4k
Hideki Mochizuki Japan	57	3.8k 0.9×	2.9k 1.1×	1.8k 0.9×	3.8k 2.0×	647 0.6×	436	11.4k
Turgay Dalkara Türkiye	47	3.3k 0.8×	2.0k 0.8×	2.6k 1.3×	1.8k 0.9×	474 0.4×	158	11.5k
Erlend A. Nagelhus Norway	39	4.4k 1.0×	5.8k 2.2×	1.4k 0.7×	2.7k 1.4×	456 0.4×	74	11.8k
George S. Robertson Canada	49	4.4k 1.1×	4.5k 1.7×	1.1k 0.5×	1.5k 0.8×	614 0.6×	170	9.4k
Claudia Verderio Italy	62	5.8k 1.4×	3.4k 1.3×	1.4k 0.7×	937 0.5×	1.3k 1.2×	131	11.1k
Günter U. Höglinger Germany	55	3.0k 0.7×	3.1k 1.2×	2.2k 1.1×	5.2k 2.6×	501 0.4×	284	10.8k

Countries citing papers authored by Andreas Jeromin

Since Specialization

Citations

This map shows the geographic impact of Andreas Jeromin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Jeromin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Jeromin more than expected).

Fields of papers citing papers by Andreas Jeromin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Jeromin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Jeromin. The network helps show where Andreas Jeromin may publish in the future.

Co-authorship network of co-authors of Andreas Jeromin

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Jeromin. A scholar is included among the top collaborators of Andreas Jeromin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Jeromin. Andreas Jeromin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Snyder, Peter J., Jessica Alber, Charles Murchison, et al.. (2025). Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer’s disease. Alzheimer s Research & Therapy. 17(1). 19–19. 4 indexed citations

Bali, Divya, Shorena Janelidze, Gemma Salvadó, et al.. (2024). Comparison of plasma ALZpath p‐Tau217 with Lilly p‐Tau217 and p‐Tau181. Alzheimer s & Dementia. 20(S2).

Chiotis, Konstantinos, Marco Bucci, Irina Savitcheva, et al.. (2024). Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics. EBioMedicine. 112. 105504–105504. 3 indexed citations

Harten, Argonde C. van, Afina W. Lemstra, Yolande A.L. Pijnenburg, et al.. (2024). Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(4). e70003–e70003. 6 indexed citations

Vanbrabant, Jeroen, Sjors G. J. G. In ‘t Veld, Rebecca M. Edelmayer, et al.. (2023). Plasma phosphorylated tau 217 levels are highly stable under common pre‐analytical sample handling procedures. Alzheimer s & Dementia. 19(S14). 1 indexed citations

Benedet, Andréa Lessa, Gallen Triana‐Baltzer, Guglielmo Di Molfetta, et al.. (2023). Plasma pTau217: single vs multiple phospho‐site assays.. Alzheimer s & Dementia. 19(S24). 2 indexed citations

Andréasson, Ulf, Johan Gobom, Vincent Delatour, et al.. (2023). Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood. Clinical Chemistry and Laboratory Medicine (CCLM). 61(7). 1245–1254. 21 indexed citations

Molfetta, Guglielmo Di, Andreas Jeromin, Eugeen Vanmechelen, et al.. (2023). The detection of phosphorylated tau in tear fluid. Alzheimer s & Dementia. 19(S24). 1 indexed citations

Wilde, Elisabeth A., Kimbra Kenney, Jessica Gill, et al.. (2022). A Framework to Advance Biomarker Development in the Diagnosis, Outcome Prediction, and Treatment of Traumatic Brain Injury. Journal of Neurotrauma. 39(7-8). 436–457. 44 indexed citations

10.

Nilsson, Johanna, Nicholas J. Ashton, Andréa Lessa Benedet, et al.. (2022). Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 78–78. 22 indexed citations

11.

Frankel, Michael, Sharon D. Yeatts, Andreas Jeromin, et al.. (2019). Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III. Journal of Neurotrauma. 36(20). 2863–2871. 26 indexed citations

12.

Schaepdryver, Maxim De, Steffi De Meyer, Andreas Jeromin, et al.. (2019). Serum neurofilament heavy chains as early marker of motor neuron degeneration. Annals of Clinical and Translational Neurology. 6(10). 1971–1979. 35 indexed citations

13.

Devos, David, Caroline Moreau, Maéva Kyheng, et al.. (2019). A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports. 9(1). 2918–2918. 114 indexed citations

14.

Nakamura, Tomoe Y., Andreas Jeromin, Katsuhiko Mikoshiba, & Shigeo Wakabayashi. (2011). Neuronal Calcium Sensor-1 Promotes Immature Heart Function and Hypertrophy by Enhancing Ca ²⁺ Signals. Circulation Research. 109(5). 512–523. 44 indexed citations

15.

Mondello, Stefania, Andreas Jeromin, Jackson Streeter, et al.. (2011). Abstract 13492: Glial Fibrillary Acidic Protein, a Sensitive and Specific Marker in Serum for the Identification of Intracerebral Hemorrhage in Acute Stroke Patients: Results of Improved Assay Performance. Circulation. 124. 1 indexed citations

16.

Souza, Bruno Rezende, Débora Marques de Miranda, Renan P. Souza, et al.. (2010). Lack of effects of typical and atypical antipsychotics in DARPP-32 and NCS-1 levels in PC12 cells overexpressing NCS-1. Journal of Negative Results in BioMedicine. 9(1). 4–4. 15 indexed citations

17.

El-Haou, Saïd, Elise Balse, Nathalie Neyroud, et al.. (2009). Kv4 Potassium Channels Form a Tripartite Complex With the Anchoring Protein SAP97 and CaMKII in Cardiac Myocytes. Circulation Research. 104(6). 758–769. 66 indexed citations

18.

Reece, Jeff, et al.. (2008). Synapse elimination accompanies functional plasticity in hippocampal neurons. Proceedings of the National Academy of Sciences. 105(8). 3123–3127. 158 indexed citations

19.

Nakamura, Tomoe Y., Andreas Jeromin, George M. Smith, et al.. (2006). Novel role of neuronal Ca2+ sensor-1 as a survival factor up-regulated in injured neurons. The Journal of Cell Biology. 172(7). 1081–1091. 56 indexed citations

20.

Rosa, Daniela Valadão, Renan P. Souza, Bruno Rezende Souza, et al.. (2006). NCS-1 Expression in Rat Brain after Electroconvulsive Stimulation. Neurochemical Research. 32(1). 81–85. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact